• Deracoxib (SKU B1091): Reliable COX-2 Inhibition for Assays

  2026-04-25

  This article provides scenario-driven, evidence-based guidance for researchers using Deracoxib (SKU B1091) in cell viability, proliferation, and cytotoxicity assays. We address protocol optimization, data interpretation, and vendor selection with actionable insights, linking peer-reviewed literature and APExBIO’s product specifications for reliable cyclooxygenase-2 inhibition.

• Nystatin (Fungicidin) in Advanced Antifungal Assays: Mechani

  2026-04-24

  Explore the unique mechanistic depth and translational value of Nystatin (Fungicidin) as a polyene antifungal agent. This article offers an in-depth analysis of its molecular action, assay optimization, and research applications, providing perspectives not covered in standard reviews.

• Cerium Oxide Nanoparticle Delivery System for Neuropathic Pa

  2026-04-24

  Tian et al. present a magnetically targeted, mesoporous silica-based nanoplatform (FMCCC) integrating a CGRP antagonist, curcumin, and cerium oxide to address neuropathic pain in a mouse model. Their findings demonstrate robust inhibition of oxidative stress and inflammation, marking a significant advance in multimodal pain therapeutics with implications for translational nanomedicine.

• Energy Deficiency, ATG4B, and DNA Repair Impairment in AML P

  2026-04-23

  This study reveals a mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). By demonstrating that nuclear translocation of ATG4B inhibits PRMT1-mediated methylation of MRE11, the authors explain how metabolic stress accelerates AML progression and suggest ATG4B as a potential therapeutic target.

• Primidone (Mysoline): TRPM3 and RIPK1 Inhibition for Transla

  2026-04-23

  This thought-leadership article explores the mechanistic, experimental, and translational significance of Primidone (Mysoline) as a dual TRPM3 and RIPK1 inhibitor. We synthesize structural and functional evidence, contextualize animal and clinical protocols, delineate strategic guidance for translational researchers, and map the competitive landscape. Expanding beyond typical product summaries, the article connects recent molecular revelations to actionable protocol parameters, highlights APExBIO’s product provenance, and provides a forward-looking outlook for the field.

• Viral Control of RIPK3 Degradation and Necroptosis in Inflam

  2026-04-22

  This study identifies a viral strategy in orthopoxviruses that targets and degrades RIPK3, a key necroptosis adaptor, thus dampening virus-induced inflammation. The findings highlight a critical evolutionary mechanism in virus-host interactions and provide new context for cell death pathway research.

• Sodium Picosulfate: Atomic Benchmarks and Protocol Insights

  2026-04-22

  Sodium Picosulfate is a stimulant laxative with well-documented efficacy and defined chemical parameters. It inhibits electrolyte absorption and stimulates colonic secretion, offering reliable solutions for chronic and opioid-induced constipation management. This article provides atomic, evidence-based facts, protocol standards, and application limits.

• Bifendate (DDB): Advancing Hepatoprotection and Autophagy In

  2026-04-21

  Bifendate (DDB) streamlines liver research with robust hepatoprotection, precise autophagy inhibition, and reliable lipid regulation. This guide details data-backed workflows, troubleshooting, and the latest assay innovations to maximize reproducibility in hepatic models.

• PBS Liposomes: Optimizing Macrophage Depletion Controls in V

  2026-04-21

  PBS Liposomes provide an inert, gold-standard control for discerning clodronate-specific effects in macrophage depletion studies. Their robust uptake and non-cytotoxic profile drive precise immunological assays and boost reproducibility in in vivo models.

• Fludarabine: DNA Synthesis Inhibitor Workflows & Assay Tips

  2026-04-20

  Fludarabine stands out as a precision DNA synthesis inhibitor, enabling robust cell cycle arrest and apoptosis assays in leukemia and multiple myeloma research. This guide translates both mechanistic insights and advanced troubleshooting into actionable workflows for maximizing experimental reliability and translational value.

• GSK-923295: Applied CENP-E Inhibitor Workflows in Cancer Res

  2026-04-20

  GSK-923295, a precise CENP-E inhibitor, empowers researchers to dissect mitotic arrest and chromosome alignment with unmatched reproducibility. This guide details advanced protocols, troubleshooting, and real-world optimizations for leveraging GSK-923295 in cancer research and mitosis assays.

• Berberine–Evodiamine Synergy in GERD: TAS2R38/TRPV1, MAPK/NF

  2026-04-19

  Cui et al. (2024) demonstrate that combined berberine and evodiamine treatment alleviates gastroesophageal reflux disease (GERD) by modulating TAS2R38/TRPV1 and downstream MAPK/NF-κB signaling, promoting epithelial repair and anti-inflammatory macrophage polarization. This integrative approach reveals new therapeutic targets and highlights the utility of advanced cell biology tools for mechanistic studies.

• Mechanisms of Spiroplasma eriocheiris Entry into Drosophila

  2026-04-18

  This study elucidates how Spiroplasma eriocheiris invades Drosophila Schneider 2 cells, revealing that clathrin-mediated endocytosis and macropinocytosis are essential for cellular entry, while caveolae-dependent pathways and cholesterol disruption play no significant role. These insights refine experimental modeling of Spiroplasma pathogenesis and highlight key differences in host-pathogen interactions relevant to invertebrate systems.

• DiD (DiDC 18 (5)) Plasma Membrane Probe: Protocols & Innovat

  2026-04-17

  DiD (DiDC 18 (5)) enables high-fidelity plasma membrane labeling in complex tissue and cell tracking applications, excelling even in high-autofluorescence environments. This article translates recent research and best-practice workflows into actionable guidance for maximizing the probe’s potential in advanced imaging and cell migration studies.

• APEX2 Regulates TERT Expression in Human Embryonic Stem Cell

  2026-04-16

  This study uncovers a novel regulatory function for APEX2 in sustaining telomerase (TERT) expression in human embryonic stem cells. By linking DNA repair enzyme activity to telomerase gene control, the work opens new perspectives in stem cell biology and cancer research.

16085 records 1/1073 page Next 12345 下5页 Last page